ClassID:

96493

C07J7/00 - CPC Classification

Classification description:

Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms

Sub-classes:
Recent Application in this class:
#1
20250319106
2025-10-16

19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF

#2
20220289788
2022-09-15

3-HYDROXY-5-PREGNANE-20-ONE DERIVATIVE AND USE THEREOF

#3
20220110950
2022-04-14

19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof

#4
20200155576
2020-05-21

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

#5
20200016178
2020-01-16

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

#6
20180311262
2018-11-01

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

#7
20180141971
2018-05-24

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

#8
20170246191
2017-08-31

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

#9
20170051008
2017-02-23

Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties

#10
20160108080
2016-04-21

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

#11
20160083417
2016-03-24

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

#12
20150005518
2015-01-01

Process for alkynylating 16-substituted-17-keto steroids

#13
20140094619
2014-04-03

Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties

#14
20140011779
2014-01-09

Steroids having increased water solubility and resistance against metabolism, and methods for their production

#15
20140005132
2014-01-02

Contraceptive agents

#16
20130281421
2013-10-24

Steroids having increased water solubility and resistance against metabolism and methods for their production

#17
20130217903
2013-08-22

Process for preparing a crystalline form of halobetasol propionate

#18
20110124044
2011-05-26

Method of producing tibolone metabolites by fermentation with

#19
20110124043
2011-05-26

Method of producing tibolone metabolites by fermentation with

#20
20110124042
2011-05-26

Method of producing tibolone metabolites by fermentation with

#21
20110124041
2011-05-26

Method of producing tibolone metabolites by fermentation with

#22
20110092473
2011-04-21

Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties

#23
20100130760
2010-05-27

Process for preparing a crystalline form of halobetasol propionate

#24
20100120736
2010-05-13

Mineralocorticoid Receptor Antagonists

#25
20100113408
2010-05-06

21-substituted progesterone derivatives as new antiprogestational agents

#26
20090137542
2009-05-28

Alpha-glucosidase inhibitors from fungal hydroxylation of tibolone and hydroxytibolones

#27
20090136434
2009-05-28

Tyrosinase enzyme inhibitors from fungal hydroxylation of tibolone

#28
20090069584
2009-03-12

Levonorgestrel Crystallization

#29
20090012321
2009-01-08

PROCESS FOR PREPARING 17ALPHA-ACETOXY-6-METHYLENEPREGN-4-ENE-3,20-DIONE, MEDROXYPROGESTERONE ACETATE AND MEGESTROL ACETATE

#30
20080119416
2008-05-22

Steroids having increased water solubility and resistance against metabolism, and methods for their production

#31
20070298456
2007-12-27

Microbiological process for the production of 7-substitued 11-hydroxy steroids, 7,17-substituted 11-halogen steroids, and uses thereof

#32
20070167420
2007-07-19

Process for preparing a crystalline form of halobetasol propionate

#33
20070155781
2007-07-05

Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders

#34
20070117974
2007-05-24

One-pot processes for preparing prednisolone derivatives

#35
20070105828
2007-05-10

Novel polymorph form M of mifepristone and process for its preparation

#36
20070037782
2007-02-15

Therapeutic agent for ageing macular degeneration

#37
20070015740
2007-01-18

Derivative prodrugs of ethinyl estradiol

#38
20060276443
2006-12-07

21-substituted progesterone derivatives as new antiprogestational agents

#39
20060183727
2006-08-17

Estrogenic compounds as anti-mitotic agents

#40
20060178520
2006-08-10

Process for preparing medrogestone

#41
20060166955
2006-07-27

Production process for 16-dehydropregnenoneol and its analogs

#42
20060149045
2006-07-06

Steroid compounds with anti-tumor activity

#43
20060148773
2006-07-06

Novel steroidal antiestrogens and antiandrogens and uses thereof

#44
20060140816
2006-06-29

Sterilization of beclomethasone drug particles for pulmonary delivery

#45
20060111577
2006-05-25

Method for preparing 17 alpha-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates

#46
20050143365
2005-06-30

Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents

#47
20050143364
2005-06-30

21-substituted progesterone derivatives as new antiprogestational agents

#48
20050090477
2005-04-28

Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-Halogen steroids and uses thereof

#49
20050085452
2005-04-21

Process for the synthesis of pharmacologically active (z/e)-guggulsterones

#50
20050065135
2005-03-24

8β-vinyl-11β-(ω-substituted)alkyl-estra-1,3,5(10)-trienes